Skip to main content

Table 12 Incidence of death compared to various factors

From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients

 

No death

Death

Test value

p-value

Sig.

No. = 24

No. = 9

Interval from symptom onset to treatment

 Median (IQR)

8 (5–12)

5 (3–7)

−1.524b

0.127

NS

 Range

2–63

1–14

Endoscopic treatment

19 (79.2%)

5 (55.6%)

1.840a

0.175

NS

Combined (endoscopic and external)

4 (16.7%)

3 (33.3%)

1.088a

0.297

NS

External

2 (8.3%)

0 (0.0%)

0.798a

0.372

NS

Total no. of surgical procedures

 0

1 (4.8%)

1 (14.3%)

4.000a

0.261

NS

 1

12 (57.1%)

6 (85.7%)

 2

7 (33.3%)

0 (0.0%)

 3

1 (4.8%)

0 (0.0%)

Inf. turb.

23 (95.8%)

9 (100.0%)

0.387a

0.534

NS

Middle turb.

22 (91.7%)

9 (100.0%)

0.798a

0.372

NS

MMA

23 (95.8%)

9 (100.0%)

0.387a

0.534

NS

Septectomy

11 (45.8%)

6 (66.7%)

1.137a

0.286

NS

Palatal debrid.

2 (8.3%)

1 (11.1%)

0.061a

0.805

NS

Ethmoidectomy

22 (91.7%)

9 (100.0%)

0.798a

0.372

NS

Sphenoidotomy

20 (83.3%)

5 (55.6%)

2.750a

0.097

NS

  1. P-value > 0.05, nonsignificant; P-value < 0.05, significant; P-value < 0.01, highly significant
  2. aChi-square test
  3. bMann-Whitney test
  4. •Independent t-test